Ono Pharmaceutical Co., Ltd.
4528.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥22,499,000 | ¥17,589,000 | -¥6,545,000 | ¥14,951,000 |
| Dep. & Amort. | ¥9,313,000 | ¥9,238,000 | ¥8,728,000 | ¥9,170,000 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | ¥12,461,000 | -¥24,280,000 | ¥39,077,000 | ¥3,937,000 |
| Other Non-Cash | ¥6,918,000 | ¥826,000 | -¥2,264,000 | -¥19,318,000 |
| Operating Cash Flow | ¥51,191,000 | ¥3,373,000 | ¥38,996,000 | ¥8,740,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥1,988,000 | -¥48,042,000 | -¥1,421,000 | -¥1,204,000 |
| Net Acquisitions | ¥7,000 | ¥0 | ¥0 | ¥0 |
| Inv. Purchases | -¥1,263,000 | -¥170,000 | ¥0 | ¥0 |
| Inv. Sales/Matur. | ¥4,804,000 | ¥5,769,000 | ¥0 | ¥0 |
| Other Inv. Act. | -¥334,000 | -¥600,000 | ¥16,747,000 | ¥10,023,000 |
| Investing Cash Flow | ¥1,226,000 | -¥43,043,000 | ¥15,326,000 | ¥8,819,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥7,500,000 | -¥7,500,000 | -¥8,306,000 | -¥7,500,000 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | -¥1,000 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | -¥1,369,000 | -¥17,396,000 | -¥992,000 | -¥17,770,000 |
| Other Fin. Act. | -¥834,000 | -¥861,000 | ¥0 | -¥820,000 |
| Financing Cash Flow | -¥9,704,000 | -¥25,757,000 | -¥9,298,000 | -¥26,090,000 |
| Forex Effect | ¥356,000 | -¥149,000 | -¥1,442,000 | ¥2,424,000 |
| Net Chg. in Cash | ¥43,069,000 | -¥65,576,000 | ¥43,585,000 | -¥6,108,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥138,991,000 | ¥204,567,000 | ¥160,982,000 | ¥167,090,000 |
| End Cash | ¥182,060,000 | ¥138,991,000 | ¥204,567,000 | ¥160,982,000 |
| Free Cash Flow | ¥49,531,000 | ¥1,123,000 | ¥37,575,000 | ¥7,536,000 |